Drug Trials Pharma Companies Research 
Placebo Control
JULY 31, 2013
If a sponsor gets approval from FDA to delay reporting (as is routine for all drugs that are either not approved for any indication, or being studied for a new indication – i.e., the overwhelming majority of pharma drug trials ), but doesn't post that approval on the registry, the JCO authors deem that trial “noncompliant”.
Pharmaceutical Technology
JUNE 15, 2023
Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Food and Drug Administration approval.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 4, 2022
” Conducting this kind of research in Finland makes sense, as it has a sophisticated healthcare system but a small population, which can make it challenging to carry out clinical research using traditional approaches. . “On the other hand, [they] should be able to tell a user if they are no longer reliable.”
pharmaphorum
SEPTEMBER 27, 2021
In the UK, research found that even among people working within the healthcare sector, there was greater vaccine hesitancy among every minority of healthcare workers (HCW) than among white HCWs. In 2020, 53 novel medicines were approved by the FDA and of the patients who took part in trials, just 8% were black and 6% were Asian.
Expert insights. Personalized for you.
40 
Let's personalize your content